Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bentz

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Blood|November 11, 1999
Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphomaS Stilgenbauer, D Winkler, G Ott, et al.
Leukemia|August 31, 2007
Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)S Wessendorf, T F E Barth, A Viardot, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridizationM Bentz, U S Bergerheim, C Li, et al.
Cytokines and Molecular Therapy|September 1, 1996
Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimensP Lichter, K Fischer, S Joos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2008
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimensL Trümper, C Zwick, M Ziepert, et al.
Genes, Chromosomes & Cancer|March 10, 2001
Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell lineM Bentz, T F Barth, S Brüderlein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2007
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)M Pfreundschuh, C Zwick, S Zeynalova, et al.
American Journal of Hematology|August 1, 2012
Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphomaF McClanahan, T Hielscher, M Rieger, et al.
Bone Marrow Transplantation|November 14, 2017
Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcomeV Wais, L Kündgen, S R Bohl, et al.
Scientific Reports|September 8, 2023
Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemiaR F Schlenk, D Weber, J Krzykalla, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Blood|November 11, 1999
Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphomaS Stilgenbauer, D Winkler, G Ott, et al.
Leukemia|August 31, 2007
Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)S Wessendorf, T F E Barth, A Viardot, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridizationM Bentz, U S Bergerheim, C Li, et al.
Cytokines and Molecular Therapy|September 1, 1996
Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimensP Lichter, K Fischer, S Joos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2008
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimensL Trümper, C Zwick, M Ziepert, et al.
Genes, Chromosomes & Cancer|March 10, 2001
Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell lineM Bentz, T F Barth, S Brüderlein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2007
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)M Pfreundschuh, C Zwick, S Zeynalova, et al.
American Journal of Hematology|August 1, 2012
Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphomaF McClanahan, T Hielscher, M Rieger, et al.
Bone Marrow Transplantation|November 14, 2017
Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcomeV Wais, L Kündgen, S R Bohl, et al.
Scientific Reports|September 8, 2023
Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemiaR F Schlenk, D Weber, J Krzykalla, et al.
Pageof 10